SEC Form 4 · accession 0000899243-17-027197
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Invest A/S Lundbeckfond
10% Owner
Period of report
Nov 21, 2017
Accepted (ET)
Nov 21, 2017 · 7:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 21, 2017 | C | 1,544,858 | — | A | 1,544,858 | D | |
| Common StockF2 | Nov 21, 2017 | C | 984,366 | — | A | 2,529,224 | D | |
| Common Stock | Nov 21, 2017 | P | 654,762 | $14.00 | A | 3,183,986 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF3 | — | Nov 21, 2017 | C | 11,092,383 | D | — | — | Common Stock | 1,544,858 | 0 | D |
| Series B Preferred StockF3 | — | Nov 21, 2017 | C | 7,067,945 | D | — | — | Common Stock | 984,366 | 0 | D |
Explanation of responses
- F1Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- F2Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
- F3All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis upon on November 21, 2017 and had no expiration date.